default image

Innovation Partners is a trustworthy team committed to oncology advocacy.

Joseph DiBenedetto M.D., National Oncology Consultants December 1, 2015

Innovation Partners | Consultants in Healthcare Access Strategy & Corporate and Patient Advocacy

We partner with healthcare innovators to create the access that drives commercial product development. Learn More about Innovation Partners »


Latest Blog Post:

Merck, Humana, Teva, and Government Health Regulations in the News

IP Blog | Innovation Partners | January 21, 2018

In this week’s Innovation Partners BioBlog, we share updates from companies such as Humana, Merck, and Teva. Humana has chosen to exit industry trade group AHIP, while Teva and Merck announce updates on important new drugs. This and more in this week’s Innovation Partners BioBlog. Congressional Advisory Group Supports Changes In Medicare Doctor Payments The […]

Read Full Post »

Featured Case Study:
business hand share SQ

US Market & Payer Outreach

6 Phases
 |  18 months

IP enabled client to develop relationships with key payer decision makers, which helped to increase access for their new FDA-approved product.

Read Full Post »


Featured Innovation Partners Rave:

IP was able to quickly and professionally assess our reimbursement issue and deliver a comprehensive analysis with potential solutions. Working with IP we were able to create messaging that helped our organization address customers’ concerns and create clarity for our customers. IP is easy to work with and very comprehensive in their approach to solving business issues.

Director of Surgical Marketing
Large MedTech Company


We have facilitated conversations with these organizations and many others:

* CCF is a registered trademark used with permission.
The Conquer Cancer Foundation does not endorse Innovation Partners or any company, product, service, or therapy.
Tired of getting lost in the labyrinth of the U.S. healthcare market?
Request a Free Consultation!